Atlassian Corp has a consensus price target of $229.08 based on the ratings of 27 analysts. The high is $330 issued by Cowen & Co. on January 28, 2022. The low is $147 issued by Macquarie on November 4, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Mizuho, and Capital One on July 17, 2024, July 16, 2024, and July 11, 2024, respectively. With an average price target of $218.67 between Morgan Stanley, Mizuho, and Capital One, there's an implied 23.89% upside for Atlassian Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/17/2024 | Buy Now | 27.48% | Morgan Stanley | Keith Weiss | $245 → $225 | Maintains | Overweight | Get Alert |
07/16/2024 | Buy Now | 24.65% | Mizuho | Gregg Moskowitz | $225 → $220 | Maintains | Outperform | Get Alert |
07/11/2024 | Buy Now | 19.55% | Capital One | Connor Murphy | → $211 | Upgrade | Equal-Weight → Overweight | Get Alert |
07/02/2024 | Buy Now | 27.48% | Piper Sandler | Rob Owens | $200 → $225 | Upgrade | Neutral → Overweight | Get Alert |
06/21/2024 | Buy Now | 41.64% | Wells Fargo | Michael Turrin | $285 → $250 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 18.98% | TD Cowen | Derrick Wood | $220 → $210 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 41.64% | Oppenheimer | Ittai Kidron | $300 → $250 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 13.31% | Truist Securities | Joel Fishbein | $220 → $200 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 13.31% | Piper Sandler | Rob Owens | $225 → $200 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 30.31% | Canaccord Genuity | David Hynes | $260 → $230 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | 27.48% | Mizuho | Gregg Moskowitz | $240 → $225 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | 30.31% | Baird | Rob Oliver | $270 → $230 | Maintains | Outperform | Get Alert |
04/15/2024 | Buy Now | 35.98% | Mizuho | Gregg Moskowitz | $265 → $240 | Maintains | Buy | Get Alert |
04/12/2024 | Buy Now | 50.14% | Citigroup | Fatima Boolani | $280 → $265 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 55.81% | Barclays | Ryan Macwilliams | $235 → $275 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/19/2024 | Buy Now | — | Keybanc | Jason Celino | — | Initiates | → Sector Weight | Get Alert |
02/02/2024 | Buy Now | 41.64% | UBS | Karl Keirstead | $260 → $250 | Maintains | Neutral | Get Alert |
02/02/2024 | Buy Now | 21.81% | Goldman Sachs | Kash Rangan | $188 → $215 | Maintains | Neutral | Get Alert |
01/24/2024 | Buy Now | 41.64% | Barclays | Ryan Macwilliams | $165 → $250 | Maintains | Equal-Weight | Get Alert |
01/24/2024 | Buy Now | 61.47% | Wells Fargo | Michael Turrin | $275 → $285 | Maintains | Overweight | Get Alert |
01/22/2024 | Buy Now | 58.64% | Citigroup | Fatima Boolani | $215 → $280 | Maintains | Buy | Get Alert |
01/16/2024 | Buy Now | 50.14% | Mizuho | Gregg Moskowitz | $240 → $265 | Maintains | Buy | Get Alert |
01/16/2024 | Buy Now | 24.65% | Truist Securities | Joel Fishbein | $180 → $220 | Maintains | Hold | Get Alert |
12/01/2023 | Buy Now | 4.82% | Scotiabank | Nick Altmann | → $185 | Initiates | → Sector Perform | Get Alert |
11/03/2023 | Buy Now | 1.98% | Truist Securities | Joel Fishbein | $200 → $180 | Maintains | Hold | Get Alert |
11/03/2023 | Buy Now | 1.98% | Piper Sandler | Rob Owens | $200 → $180 | Maintains | Neutral | Get Alert |
10/02/2023 | Buy Now | 27.48% | UBS | Karl Keirstead | → $225 | Initiates | → Neutral | Get Alert |
09/19/2023 | Buy Now | 35.98% | Mizuho | Gregg Moskowitz | $240 → $240 | Maintains | Buy | Get Alert |
08/30/2023 | Buy Now | 30.31% | Citigroup | Fatima Boolani | $195 → $230 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 24.65% | BMO Capital | Keith Bachman | $180 → $220 | Maintains | Market Perform | Get Alert |
08/04/2023 | Buy Now | 4.82% | Morgan Stanley | Keith Weiss | $185 → $185 | Reiterates | Overweight → Overweight | Get Alert |
08/04/2023 | Buy Now | 13.31% | Truist Securities | Joel Fishbein | $150 → $200 | Maintains | Hold | Get Alert |
08/04/2023 | Buy Now | 35.98% | Baird | Rob Oliver | $205 → $240 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 30.31% | Wells Fargo | Michael Turrin | $200 → $230 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | 33.14% | Oppenheimer | Ittai Kidron | $200 → $235 | Maintains | Outperform | Get Alert |
08/04/2023 | Buy Now | 35.98% | Mizuho | Gregg Moskowitz | $205 → $240 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 10.48% | Barclays | Ryan Macwilliams | $165 → $195 | Maintains | Equal-Weight | Get Alert |
07/25/2023 | Buy Now | -6.52% | Barclays | Ryan Macwilliams | $130 → $165 | Maintains | Equal-Weight | Get Alert |
07/24/2023 | Buy Now | 16.15% | Baird | Rob Oliver | $175 → $205 | Maintains | Outperform | Get Alert |
07/18/2023 | Buy Now | 16.15% | Keybanc | Steve Enders | $175 → $205 | Maintains | Overweight | Get Alert |
07/12/2023 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
06/29/2023 | Buy Now | -15.01% | Berenberg | Andrew DeGasperi | → $150 | Initiates | → Hold | Get Alert |
05/31/2023 | Buy Now | 13.31% | Wells Fargo | Michael Turrin | $180 → $200 | Maintains | Overweight | Get Alert |
05/08/2023 | Buy Now | -26.35% | Barclays | Ryan Macwilliams | $155 → $130 | Maintains | Equal-Weight | Get Alert |
05/05/2023 | Buy Now | -12.18% | BMO Capital | Keith Bachman | $190 → $155 | Maintains | Market Perform | Get Alert |
05/05/2023 | Buy Now | 1.98% | Wells Fargo | Michael Turrin | $200 → $180 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | 21.81% | Mizuho | Gregg Moskowitz | $235 → $215 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | -6.52% | Goldman Sachs | Kash Rangan | $240 → $165 | Downgrade | Buy → Neutral | Get Alert |
04/20/2023 | Buy Now | 5.95% | Keybanc | Steve Enders | $174 → $187 | Maintains | Overweight | Get Alert |
04/17/2023 | Buy Now | 13.31% | Oppenheimer | Ittai Kidron | → $200 | Reiterates | → Outperform | Get Alert |
04/17/2023 | Buy Now | 33.14% | Mizuho | Gregg Moskowitz | $255 → $235 | Maintains | Buy | Get Alert |
04/14/2023 | Buy Now | 7.65% | BMO Capital | Keith Bachman | $170 → $190 | Maintains | Market Perform | Get Alert |
02/03/2023 | Buy Now | -0.85% | Canaccord Genuity | David Hynes | $150 → $175 | Maintains | Buy | Get Alert |
02/03/2023 | Buy Now | 4.82% | Morgan Stanley | Keith Weiss | $190 → $185 | Maintains | Overweight | Get Alert |
02/03/2023 | Buy Now | -9.35% | Piper Sandler | Rob Owens | $140 → $160 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | 1.98% | Jefferies | Brent Thill | $150 → $180 | Maintains | Buy | Get Alert |
01/06/2023 | Buy Now | 13.31% | Wells Fargo | Michael Turrin | $250 → $200 | Maintains | Overweight | Get Alert |
01/05/2023 | Buy Now | -15.01% | Jefferies | Brent Thill | → $150 | Upgrade | Hold → Buy | Get Alert |
12/22/2022 | Buy Now | 7.65% | Baird | Rob Oliver | $210 → $190 | Maintains | Outperform | Get Alert |
11/29/2022 | Buy Now | -14.45% | BMO Capital | Keith Bachman | $160 → $151 | Maintains | Market Perform | Get Alert |
11/11/2022 | Buy Now | 7.65% | Morgan Stanley | Keith Weiss | $375 → $190 | Maintains | Overweight | Get Alert |
11/07/2022 | Buy Now | 18.98% | Citigroup | Fatima Boolani | $375 → $210 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 41.64% | Wells Fargo | Michael Turrin | $325 → $250 | Maintains | Overweight | Get Alert |
11/04/2022 | Buy Now | -9.35% | BMO Capital | Keith Bachman | $295 → $160 | Maintains | Market Perform | Get Alert |
11/04/2022 | Buy Now | -16.71% | Macquarie | Frederick Havemeyer | $287 → $147 | Downgrade | Outperform → Neutral | Get Alert |
11/04/2022 | Buy Now | 50.14% | Goldman Sachs | Kash Rangan | $300 → $265 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 18.98% | Baird | Rob Oliver | $380 → $210 | Maintains | Outperform | Get Alert |
11/04/2022 | Buy Now | 44.48% | Mizuho | Gregg Moskowitz | $320 → $255 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | — | Piper Sandler | James Fish | — | Downgrade | Overweight → Neutral | Get Alert |
10/31/2022 | Buy Now | 24.65% | Jefferies | Brent Thill | $260 → $220 | Maintains | Hold | Get Alert |
10/20/2022 | Buy Now | 112.46% | Morgan Stanley | Keith Weiss | $430 → $375 | Maintains | Overweight | Get Alert |
10/17/2022 | Buy Now | 81.3% | Mizuho | Gregg Moskowitz | $360 → $320 | Maintains | Buy | Get Alert |
08/08/2022 | Buy Now | 64.31% | Wolfe Research | Joshua Tilton | $240 → $290 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 41.64% | Truist Securities | Joel Fishbein | $220 → $250 | Maintains | Hold | Get Alert |
08/05/2022 | Buy Now | 60.34% | Piper Sandler | James Fish | $249 → $283 | Maintains | Overweight | Get Alert |
08/05/2022 | Buy Now | 115.3% | Baird | Rob Oliver | $520 → $380 | Maintains | Outperform | Get Alert |
07/22/2022 | Buy Now | 112.46% | Citigroup | Fatima Boolani | $435 → $375 | Maintains | Buy | Get Alert |
07/22/2022 | Buy Now | 57.51% | Keybanc | Michael Turits | $338 → $278 | Maintains | Overweight | Get Alert |
07/20/2022 | Buy Now | 45.61% | Bernstein | Peter Weed | → $257 | Initiates | → Outperform | Get Alert |
07/13/2022 | Buy Now | 41.08% | Piper Sandler | James Fish | $371 → $249 | Maintains | Overweight | Get Alert |
07/11/2022 | Buy Now | 143.63% | Morgan Stanley | Keith Weiss | $460 → $430 | Maintains | Overweight | Get Alert |
06/27/2022 | Buy Now | 69.97% | Goldman Sachs | Kash Rangan | $279 → $300 | Upgrade | Neutral → Buy | Get Alert |
05/23/2022 | Buy Now | 1.98% | Jefferies | Brent Thill | $275 → $180 | Maintains | Hold | Get Alert |
05/18/2022 | Buy Now | 69.97% | Wells Fargo | Michael Turrin | $400 → $300 | Maintains | Overweight | Get Alert |
05/16/2022 | Buy Now | 103.97% | Mizuho | Gregg Moskowitz | $500 → $360 | Maintains | Buy | Get Alert |
04/29/2022 | Buy Now | 160.62% | Morgan Stanley | Keith Weiss | $505 → $460 | Maintains | Overweight | Get Alert |
04/22/2022 | Buy Now | 126.63% | Wells Fargo | Michael Turrin | $425 → $400 | Maintains | Overweight | Get Alert |
04/08/2022 | Buy Now | 117.56% | Piper Sandler | James Fish | $414 → $384 | Maintains | Overweight | Get Alert |
04/08/2022 | Buy Now | 124.93% | Keybanc | Steve Enders | $442 → $397 | Maintains | Overweight | Get Alert |
03/24/2022 | Buy Now | 112.46% | Truist Securities | Joel Fishbein | $400 → $375 | Maintains | Hold | Get Alert |
03/15/2022 | Buy Now | 140.79% | Wells Fargo | Michael Turrin | $500 → $425 | Maintains | Overweight | Get Alert |
01/28/2022 | Buy Now | 86.97% | Cowen & Co. | Derrick Wood | $325 → $330 | Maintains | Market Perform | Get Alert |
01/20/2022 | Buy Now | 84.14% | Cowen & Co. | Derrick Wood | $380 → $325 | Maintains | Market Perform | Get Alert |
12/16/2021 | Buy Now | 112.46% | Goldman Sachs | Kash Rangan | — | Initiates | → Neutral | Get Alert |
10/29/2021 | Buy Now | 197.45% | Mizuho | Gregg Moskowitz | — | Maintains | Buy | Get Alert |
10/29/2021 | Buy Now | 183.29% | Wells Fargo | Michael Turrin | — | Maintains | Overweight | Get Alert |
10/29/2021 | Buy Now | 183.29% | Oppenheimer | Ittai Kidron | — | Maintains | Outperform | Get Alert |
10/22/2021 | Buy Now | 186.12% | Morgan Stanley | Keith Weiss | — | Maintains | Overweight | Get Alert |
10/19/2021 | Buy Now | 103.97% | Cowen & Co. | Derrick Wood | — | Maintains | Market Perform | Get Alert |
10/08/2021 | Buy Now | 149.29% | Mizuho | Gregg Moskowitz | — | Maintains | Buy | Get Alert |
The latest price target for Atlassian (NASDAQ:TEAM) was reported by Morgan Stanley on July 17, 2024. The analyst firm set a price target for $225.00 expecting TEAM to rise to within 12 months (a possible 27.48% upside). 39 analyst firms have reported ratings in the last year.
The latest analyst rating for Atlassian (NASDAQ:TEAM) was provided by Morgan Stanley, and Atlassian maintained their overweight rating.
The last upgrade for Atlassian Corp happened on July 11, 2024 when Capital One raised their price target to $211. Capital One previously had an equal-weight for Atlassian Corp.
The last downgrade for Atlassian Corp happened on July 12, 2023 when OTR Global changed their price target from N/A to N/A for Atlassian Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Atlassian, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Atlassian was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
While ratings are subjective and will change, the latest Atlassian (TEAM) rating was a maintained with a price target of $245.00 to $225.00. The current price Atlassian (TEAM) is trading at is $176.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.